Mesoblast Ltd.
Description Mesoblast Limited engages in the development, manufacture, and commercialization of biologic products for the field of regenerative medicine. It is involved in the development of its mesenchymal precursor cell technology for a range of major clinical diseases, including inflammatory and immunologic conditions, diabetes and its complications, orthopedic spine conditions, cardiovascular disorders, bone marrow transplantation, and eye diseases. The company has strategic alliances with Cephalon Inc. to develop and commercialize its adult stem cell therapeutics for degenerative conditions of the cardiovascular and central nervous systems; and Lonza Group for the clinical and long-term commercial production of its allogeneic adult stem cell products. Mesoblast Limited was incorporated in 2004 and is based in Melbourne, Australia. To view the detailed information, you need to SUBSCRIBE with us. |
 |